What is COMPASS?

COMPASS is a study funded by the National Institutes of Health that aims to better the emotional wellbeing of primary caregivers of allogeneic “allo” bone marrow transplant (BMT) patients at Moffitt Cancer Center.


Why Participate in COMPASS?

Caregivers have an intensive, long-term role in the recovery of allo transplant patients that can involve distress and other negative emotional outcomes. Helping caregivers deal with this stress can not only help caregivers, but might also improve patient outcomes.